Over 10 years, mesenchymal stem cells (MSCs) have been considered as valuable and
suitable cells for cell-based therapy applications, particularly in clinical trials. In any case …

Mesenchymal stromal cells (MSCs) have been widely investigated for regenerative
medicine applications, from treating various inflammatory diseases as a cell therapy to …

Reno‐protective strategies are needed to improve renal outcomes in patients with
atherosclerotic renal artery stenosis (ARAS). Adipose tissue‐derived mesenchymal stem …

Mesenchymal stem cell therapy show great optimism in the treatment of several diseases.
MSCs are attractive candidates for cell therapy because of easy isolation, high expansion …

Intercellular communication between mesenchymal stem cells (MSC s) and their target cells
in the perivascular environment is modulated by exosomes derived from MSC s. However …

The present study aims to explore the protective effect of human bone marrow mesenchymal
stem cells (hBMSCs) on radiation‐induced aortic injury (RIAI). hBMSCs were isolated and …

Abstract Information on the biodistribution (BD) of cell therapy products (CTPs) is essential
for prediction and assessment of their efficacy and toxicity profiles in non-clinical and clinical …

Background Restenosis is inevitable when patients undergo percutaneous transluminal
angioplasty due to neointimal hyperplasia (NIH). Human umbilical cord mesenchymal stem …

摘要背景: 随着干细胞研究的发展, 成体干细胞如内皮祖细胞和间充质干细胞在动脉粥样硬化,
血管支架植入损伤并发症中的治疗效能逐渐被发现, 由于静脉输注成体干细胞治疗疾病存在靶向 …

Mesenchymal stem cells (MSCs) show immunosuppressive activities and alleviate
atherosclerosis (AS) formation in apolipoprotein E‑knockout (apoE‑KO) mice. Human …